Laboratory News and Research

RSS

Researchers uncover potential new target for anti-COVID-19 therapies

Researchers from Cleveland Clinic's Florida Research and Innovation Center have identified a potential new target for anti-COVID-19 therapies.

16 Mar 2021

Sex differences play roles in how patients respond to brain diseases

Men and women are impacted differently by brain diseases, like Alzheimer's disease and Parkinson's disease. Researchers are urging their colleagues to remember those differences when researching treatments and cures.

16 Mar 2021

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

A new piece of research, published on the medRxiv preprint server, focused on the role of factors such as gender, age, hospitalization, etc., in understanding the risks of clinical sequelae in the post-acute phase of COVID-19, in adults aged between 18 and 65 years.

15 Mar 2021

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research.

15 Mar 2021

Synthesis of photocatalytic and antibacterial materials for removing medicines from wastewater

The Theoretical and Computational Chemistry Laboratory (QTC) of the Jaume I University of Castellón (UJI), in collaboration with the Centre for the Development of Functional Materials (CDMF) of the Universidad Federal de São Carlos (UFSCar), has published an article entitled “Selective Synthesis of α-, β-, and γ-Ag2WO4 Polymorphs: Promising Platforms for Photocatalytic and Antibacterial Materials” in scientific journal Inorganic Chemistry, which showcases new photocatalytic and antibacterial materials to remove medicines from wastewater.

15 Mar 2021

New cancer immunotherapy uses engineered T cells to target a common genetic alteration

Researchers developed a prototype for a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers.

15 Mar 2021

MGH researchers uncover new clues about X chromosome inactivation

Researchers at Massachusetts General Hospital have uncovered new clues that add to the growing understanding of how female mammals, including humans, "silence" one X chromosome.

15 Mar 2021

Upgrade Your Sample Management Workflow

Ziath has introduced an easy upgrade path for the many users of DataPaq 3 sample management software products to its powerful new DP5 suite of products.

From Ziath Ltd 15 Mar 2021

HORIBA Medical launches new look blood cell morphology educational newsletter

HORIBA UK Ltd, Medical announces that it has launched its new look blood cell morphology-focused newsletter.

From HORIBA Medical 15 Mar 2021

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

A recent study, currently available on the bioRxiv preprint server, indicates that a pair of dual-action monoclonal antibodies derived from an original 2003 SARS survivors could play an important role in the fight against coronavirus disease 2019 (COVID-19) due to their broadly neutralizing activity and the engagement of the immune system via effector function capabilities.

14 Mar 2021

An individualized approach to improve surgical outcomes after shoulder dislocation

A dislocated shoulder is a common sports injury that can occur with a single swing of the tennis racket or an awkward fall on the field. Though popping the bone back into the socket may seem like a simple solution, the reality is more complex.

13 Mar 2021

Cancer cells may dodge chemotherapy by going into 'active hibernation'

Cancer cells can dodge chemotherapy by entering a state that bears similarity to certain kinds of senescence, a type of "active hibernation" that enables them to weather the stress induced by aggressive treatments aimed at destroying them, according to a new study by scientists at Weill Cornell Medicine.

13 Mar 2021

Otago researchers find how to treat heart disease in type-2 diabetics

University of Otago researchers have discovered one of the reasons why more than 50 per cent of people with type 2 diabetes die from heart disease.

12 Mar 2021

Pooling COVID-19 tests to detect future outbreaks

How could pooling SARS-CoV-2 tests help to detect future viral outbreaks? News-Medical spoke to Dr. Jean-François Rupprecht to find out more.

12 Mar 2021

Deforestation in the Amazon increases diversity of antibiotic-resistant bacteria

In Brazil, a study conducted by researchers affiliated with the University of São Paulo (USP) and collaborators showed that deforestation in the Amazon causes an increase in the diversity of antibiotic-resistant bacteria.

12 Mar 2021

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.

12 Mar 2021

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.

12 Mar 2021

Exposure to COVID-19 can cause rare but life-threatening pediatric condition

Exposure to SARS-Co-V2, the virus that causes COVID-19, can put otherwise healthy children and adolescents at risk for Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but possibly life-threatening pediatric condition that can cause severe inflammation in organs like the heart, brain, lungs, kidneys and gastrointestinal system.

12 Mar 2021

Unbalanced progesterone may cause preterm or prolonged labor in some pregnant women

New research by the National Institutes of Health found that unbalanced progesterone signals may cause some pregnant women to experience preterm labor or prolonged labor.

11 Mar 2021

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials.

11 Mar 2021

Laboratory News and Research

Researchers uncover potential new target for anti-COVID-19 therapies

Sex differences play roles in how patients respond to brain diseases

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

Synthesis of photocatalytic and antibacterial materials for removing medicines from wastewater

New cancer immunotherapy uses engineered T cells to target a common genetic alteration

MGH researchers uncover new clues about X chromosome inactivation

Upgrade Your Sample Management Workflow

HORIBA Medical launches new look blood cell morphology educational newsletter

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

An individualized approach to improve surgical outcomes after shoulder dislocation

Cancer cells may dodge chemotherapy by going into 'active hibernation'

Otago researchers find how to treat heart disease in type-2 diabetics

Pooling COVID-19 tests to detect future outbreaks

Deforestation in the Amazon increases diversity of antibiotic-resistant bacteria

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Exposure to COVID-19 can cause rare but life-threatening pediatric condition

Unbalanced progesterone may cause preterm or prolonged labor in some pregnant women

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Lab Diagnostics and Automation - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News